Log in
Enquire now
Edesa Biotech

Edesa Biotech

Edesa Biotech is a Markham, Ontario-based biotechnology company working on non-steroidal topical treatment alternatives for inflammatory and autoimmune diseases. Edesa Biotech is a wholly owned subsidiary of Stellar Biotechnologies.

OverviewStructured DataIssuesContributors

Contents

edesabiotech.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Dermatology
Dermatology
Autoimmune disease
Autoimmune disease
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Technology
Technology
Biology
Biology
...
Location
Port Hueneme, California
Port Hueneme, California
Markham, Ontario
Markham, Ontario
0
California
California
Canada
Canada
B2X
B2B
B2B
CEO
Par Nijhawan
Par Nijhawan
0
Pitchbook URL
pitchbook.com/profiles...186722-65
Legal Name
Edesa Biotech, Inc.
Parent Organization
Stellar Biotechnologies
Stellar Biotechnologies
Number of Employees (Ranges)
11 – 50
Email Address
info@edesabiotech.com0
Phone Number
+19054751234
+180548828000
+128980096000
Full Address
332 E. Scott St. Port Hueneme, California 93041 USA
100 Spy Court, Markham, ON L3R 5H6, CA0
CIK Number
1,540,1590
Place of Incorporation
British Columbia
British Columbia
Investors
Pharmascience
Pharmascience
Lumira Ventures
Lumira Ventures
‌
Strategic Innovation Fund (SIF)
0
Inveready Technology Investment Group
Inveready Technology Investment Group
Founded Date
2015
Total Funding Amount (USD)
7,000,000
Latest Funding Round Date
April 5, 2022
Stock Symbol
EDSA0
Exchange
Nasdaq
Nasdaq
0
Board of Directors
‌
Carlo Sistilli
0
‌
Frank Oakes
0
Par Nijhawan
Par Nijhawan
0
‌
Sean MacDonald
0
‌
Jennifer Chao
0
‌
Lorin Johnson
0
CFO
‌
Kathi Niffenegger
0
Latest Funding Type
Series A
Series A
NAICS Code
325,4120
CAGE Code
L0LU10
Country
Canada
Canada
Headquarters
Markham, Ontario
Markham, Ontario
0

Other attributes

Company Operating Status
Active
Contact Page URL
edesabiotech.com/about/...act-us/
Latest Funding Round Amount (USD)
7,000,000
SIC Code
2,8340
Ticker Symbol
EDSA

Edesa Biotech is a clinical-stage private company focused on developing treatments for dermatological and anorectal diseases. Their initial focus is on developing novel, safe and potent alternatives to steroids for allergic contact dermatitis, hemorrhoids, and anal fissures. Edesa Biotech's lead asset, EB01 is a novel non-steroidal anti-inflammatory molecule for the treatment of allergic contact dermatitis which has already demonstrated statistically significant improvements in multiple clinical studies.

Clinical Pipeline

As of April 2020, Edesa Biotech's clinical pipeline includes their EB01 topical treatment for contact dermatitis which was in Phase 2 of clinical trials; their EB01 topical treatment for hemorrhoids which was in Phase 1 of clinical trials; their EB04 topical treatment for anal fissures which was in Phase 1 of clinical trials; their EB05 and EB06 acute respiratory distress syndrome mAb treatment which were both in Phase 2 of clinical trials; and their immunotherapy for vitiligo which was heading into lead optimization as of April, 2020.

Stellar Biotechnology Merger

In May 2019, Stellar Biotechnologies shareholders approved a reverse merger with Edesa Biotech, in which the privately owned Edesa Biotech was brought onto the public market under Stellar Biotechnologies shares on the NASDAQ. As per the terms of the agreement, Edesa Biotech shareholders exchanged their shares for newly issued shares of Stellar. Edesa Biotech shareholders would own 90% of the new company. The new company retains Edesa Biotech's name, but the company has become a wholly owned subsidiary of Stellar Biotechnologies.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Edesa Biotech

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.